US 12351581
Compounds for FGFR inhibition
granted A61KA61K31/444A61K31/4545
Quick answer
US patent 12351581 (Compounds for FGFR inhibition) held by Cogent Biosciences, Inc. expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Cogent Biosciences, Inc.
- Grant date
- Tue Jul 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/444, A61K31/4545, A61K31/496, A61K31/5377